Korpi ER - Search Results

1

The in vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the alpha(2) adrenergic sedative dexmedetomidine, and cannabinoid agonists.

Linden AM, Aller MI, Leppä E, Vekovischeva O, Aitta-Aho T, Veale EL, Mathie A, Rosenberg P, Wisden W, Korpi ER. Linden AM, et al. Among authors: korpi er. J Pharmacol Exp Ther. 2006 May;317(2):615-26. doi: 10.1124/jpet.105.098525. Epub 2006 Jan 5. J Pharmacol Exp Ther. 2006. PMID: 16397088

2

The cerebellum: a model system for studying GABAA receptor diversity.

Wisden W, Korpi ER, Bahn S. Wisden W, et al. Among authors: korpi er. Neuropharmacology. 1996;35(9-10):1139-60. doi: 10.1016/s0028-3908(96)00076-7. Neuropharmacology. 1996. PMID: 9014130 Review.

3

Blunted furosemide action on cerebellar GABAA receptors in ANT rats selectively bred for high alcohol sensitivity.

Mäkelä R, Lehtonen M, Wisden W, Lüddens H, Korpi ER. Mäkelä R, et al. Among authors: korpi er. Neuropharmacology. 1996;35(9-10):1493-502. doi: 10.1016/s0028-3908(96)00073-1. Neuropharmacology. 1996. PMID: 9014165

4

Propofol-induced ataxia and hypnosis in rat lines selected for differential alcohol sensitivity.

Yildirim Y, Niemi L, Wong G, Korpi ER, Rosenberg PH. Yildirim Y, et al. Among authors: korpi er. Pharmacol Toxicol. 1997 Jan;80(1):44-8. doi: 10.1111/j.1600-0773.1997.tb00282.x. Pharmacol Toxicol. 1997. PMID: 9148282

5

Behavioral sensitivity and ethanol potentiation of the N-methyl-D-aspartate receptor antagonist MK-801 in a rat line selected for high ethanol sensitivity.

Toropainen M, Näkki R, Honkanen A, Rosenberg PH, Laurie DJ, Pelto-Huikko M, Koistinaho J, Eriksson CJ, Korpi ER. Toropainen M, et al. Among authors: korpi er. Alcohol Clin Exp Res. 1997 Jun;21(4):666-71. Alcohol Clin Exp Res. 1997. PMID: 9194922

6

Cerebellar gamma-aminobutyric acid type A receptors: pharmacological subtypes revealed by mutant mouse lines.

Mäkelä R, Uusi-Oukari M, Homanics GE, Quinlan JJ, Firestone LL, Wisden W, Korpi ER. Mäkelä R, et al. Among authors: korpi er. Mol Pharmacol. 1997 Sep;52(3):380-8. doi: 10.1124/mol.52.3.380. Mol Pharmacol. 1997. PMID: 9281599

7

GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands.

Korpi ER, Mattila MJ, Wisden W, Lüddens H. Korpi ER, et al. Ann Med. 1997 Aug;29(4):275-82. doi: 10.3109/07853899708999348. Ann Med. 1997. PMID: 9375983 Free article. Review.

8

[Better cure for anxiety, sleep disorders, epilepsy?].

Korpi ER, Wisden W, Lüddens H. Korpi ER, et al. Lakartidningen. 1997 Sep 24;94(39):3403-8. Lakartidningen. 1997. PMID: 9379810 Review. Swedish.

9

Cerebellar granule-cell-specific GABAA receptors attenuate benzodiazepine-induced ataxia: evidence from alpha 6-subunit-deficient mice.

Korpi ER, Koikkalainen P, Vekovischeva OY, Mäkelä R, Kleinz R, Uusi-Oukari M, Wisden W. Korpi ER, et al. Eur J Neurosci. 1999 Jan;11(1):233-40. doi: 10.1046/j.1460-9568.1999.00421.x. Eur J Neurosci. 1999. PMID: 9987027

10

Loreclezole and La3+ differentiate cerebellar granule cell GABA(A) receptor subtypes.

Mäkelä R, Wisden W, Korpi ER. Mäkelä R, et al. Among authors: korpi er. Eur J Pharmacol. 1999 Feb 12;367(1):101-5. doi: 10.1016/s0014-2999(98)00944-3. Eur J Pharmacol. 1999. PMID: 10082271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters